目的：观察曲安奈德对增生性瘢痕的治疗效果。
Objective to observe the effect of triamcinolone acetonide in treating hypertrophic scars.
结论：曲安奈德注射液能够有效治疗瘢痕疙瘩。
Conclusion: Keloid can be effectively treated with triamcinolone acetonide.
结论：曲安奈德是治疗增生性瘢痕的有效药物。
Conclusion Trimcinolone acetonide is effective in treating hypertrophic scars.
结论局部注射曲安奈德对增生性瘢痕的疗效较好。
Conclusion Triamcinolone acetonide by local injection has better effect to cure hypertrophic scar.
目的制备复方曲安奈德乳膏，并建立质量控制方法。
Aim to prepare compound triamcinolone acetonide cream, and establish the methods of content assay for the quality control.
目的：观察曲安奈德注射液瘢痕内注射治疗瘢痕疙瘩的疗效。
Objective: to observe the effect of injective triamcinolone acetonide for the treatment of keloid.
生理盐水组、曲安奈德组各发生细菌性眼内炎2例（20%）；
There were 2 eyes (occupying 20% ) confronted endophthalmitis in both phosphate buffered saline group and triamcinolone group respectively;
因此，染料激光联合曲安奈德局封是治疗增生性瘢痕的有效方法。
So the combination therapy is an effective method of treating hypertrophic scar.
醋酸曲安奈德通过抑制新生血管的形成，起到一定防治瘢痕的作用。
Acid triamcinolone acetonide can prevent and cure scar by inhibiting the formation of the new blood vessels.
目的观察曲安奈德联合玻璃酸钠关节腔内注射治疗骨性膝关节炎的疗效。
Objective to observe the efficacy of treatment using intra-articular triamcinolone acetonide and sodium hyaluronic in patients with knee osteoarthritis.
目的：观察醋酸曲安奈德鼻喷剂长期应用对鼻粘膜和鼻纤毛有无损害作用。
Objective: to explore the effects of triamcinolone acetonide acetate nasal spray on the animal's nasal mucosa.
目的：评价曲安奈德和透明质酸钠对山羊颞下颌关节骨关节病的治疗效果。
To investigate the efficacy of triamcinolone acetonide and sodium hyaluronate for treatment of temporomandibular joint (TMJ) osteoarthrosis of goats.
曲安奈德（TA）作为模型药物，壳聚糖与明胶作为载体，溶剂挥发法成膜。
Using triamcinolone acetonide(TA) as a model drug, the drug membranes with chitosan and gelatin as carriers are prepared through solvent volatilization.
目的观察维生素B12、曲安奈德穴位注射治疗带状疱疹后遗神经痛的疗效。
Objective To observe the effects of vitamin B12 and triamcinolone acetonide acetas injected in acupuncture points on postherpetic neuralgia.
目的建立高效液相色谱法测定曲咪新乳膏中醋酸曲安奈德及硝酸咪康唑的含量。
Objective to establish an efficient liquid phase chromatography to measure the contents of triamcinolone acetonide acetate and miconazole nitrate in Qumixin cream.
他还提出对曲安奈德进行过滤处理以及嘱患者仰卧位休息或许有利于防止这些并发症。
In addition he suggested that filtering the triamcinolone and instructing patients to sleep on their backs might prevent this complication.
目的观察球后注射曲安奈德（TA）联合激光光凝治疗糖尿病性弥漫性黄斑水肿的疗效。
Objective To investigate the effect of retrobulbar injection of triamcinolone acetonide (TA) combined with laser photocoagulation treatment on diffused diabetic macular edema.
目的：研究复方醋酸曲安奈德擦剂(华尔乐)擦剂的制备与质量标准，并观察其临床疗效。
OBJECTIVE: to study the preparation and quality standard of compound triamcinolone acetonide acetate liniment (Huaerle) liniment, and observe the clinical therapy.
结果：醋酸曲安奈德与丙酸氯倍他索抑制细胞有丝分裂作用无显著性差异（P＞0．05）。
RESULTS: There is not significant difference between clobetasol 17 propionate and triamcinolone acetonide about inhibiting the mitosis in mouse vaginal epithelium (P>0.05).
目的观察局部注射曲安奈德联合金因肽配合全身用药治疗糜烂型口腔扁平苔藓临床应用的疗效。
To observe the therapy effect of erosive type lichen planus of mouth, triamcinolone combined with RhEGF is locality injected and systemic administration is associated.
结论：曲安奈德可以帮助显示透明的玻璃体皮质，容易辨认和剥除，提高手术安全性及成功率。
CONCLUSION: TA can help to demarcate the transparent vitreous cortex and make it discernible and easy to be peeled off completely, which can improve the safety and success rate of surgery.
目的观察曲安奈德(TA)玻璃体腔注射对氧诱导视网膜新生血管的抑制作用，探讨其作用机制。
Objective to observe the inhibitory effect of intravitreal injection of triamcinolone acetonide (TA) on oxygen-induced retinal neovascularization, and to investigate its mechanism.
结果曲安奈德颗粒从眼内消失的时间，硅油填充眼为2 ~3月，非硅油填充眼为1 ~ 1.5月。
Results The clearance time of TA in silicone filled eyes was 2-3 months and 1-1.5 months in non-silicone oil filled eyes.
方法将醋酸曲安奈德、硫酸新霉素等药物与乳膏基质制成复方制剂，并采用HPLC法测定醋酸曲安奈德的含量。
Methods The compound cream was prepared with triamcinolone acetonide, neomycin sulfate, cream base, and the consistency of triamcinolone acetonide could be determined with HPLC.
以曲安奈德（TA）作为模型药物， 壳聚糖和明胶作为基体，制备治疗眼穿通伤用的复合药膜（GI CS-TA）。
Using triamcinolone acetonide(TA) as a model drug and gelatin-chitosan as carriers, the drug membranes(GICS-TA) for ocular perforating injury were prepared.
以曲安奈德（TA）作为模型药物， 壳聚糖和明胶作为基体，制备治疗眼穿通伤用的复合药膜（GI CS-TA）。
Using triamcinolone acetonide(TA) as a model drug and gelatin-chitosan as carriers, the drug membranes(GICS-TA) for ocular perforating injury were prepared.
应用推荐